0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
EUR$3,500USDGBP
Drug Overview: Dupixent - Product Thumbnail Image

Drug Overview: Dupixent

  • Report
  • February 2018
  • 27 Pages
  • Global
From
EUR$10,000USDGBP
Drug Analysis: Dupixent - Product Thumbnail Image

Drug Analysis: Dupixent

  • Drug Pipelines
  • February 2018
  • 27 Pages
  • Global
From
EUR$10,000USDGBP
EUR$249USDGBP
Loestrin 24 Fe - API Insight, 2022 - Product Thumbnail Image

Loestrin 24 Fe - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Acthar Gel - API Insight, 2022 - Product Thumbnail Image

Acthar Gel - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
Otezla - API Insight, 2022 - Product Thumbnail Image

Otezla - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
EUR$500USDGBP
From
EUR$2,095USDGBP
EUR$3,990USDGBP
From
EUR$2,095USDGBP
EUR$3,990USDGBP
From
EUR$2,095USDGBP
EUR$3,990USDGBP
From
EUR$2,095USDGBP
EUR$3,990USDGBP
From
EUR$2,095USDGBP
EUR$3,990USDGBP
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more